We can’t show the full text here under this license. Use the link below to read it at the source.
Wernicke Encephalopathy Associated With Semaglutide Use
Wernicke Encephalopathy Linked to Semaglutide Use
AI simplified
Abstract
A 37-year-old male presented to the emergency room with neurological symptoms associated with non-alcoholic Wernicke encephalopathy.
- Neurological symptoms included dysphagia, slurred speech, and word-finding difficulty.
- Non-alcoholic Wernicke encephalopathy is relatively uncommon compared to its alcoholic counterpart.
- The case occurred in the context of semaglutide use, a medication primarily used for weight management.
- Restricted extraocular movements were noted as part of the patient's clinical presentation.
AI simplified